v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash $ 872,066 $ 1,499,866
Prepaid expenses and other current assets 93,008 135,014
Deferred offering costs 35,000
TOTAL CURRENT ASSETS 965,074 1,669,880
TOTAL ASSETS 965,074 1,669,880
CURRENT LIABILITIES    
Accounts payable and accrued expenses 817,390 569,321
Accrued payroll and related expenses 346,592 95,400
Accrued series B preferred stock dividends 190,549 153,343
Convertible notes payable, net of discount 541,475 532,400
Notes payable - related parties 7,500 7,500
Debentures 35,000
TOTAL CURRENT LIABILITIES 1,903,506 1,392,964
TOTAL LIABILITIES 1,903,506 1,392,964
Redeemable convertible preferred stock - Series A; $0.0001 par value, 1,500 designated Series A, and 480 and 480 shares issued and outstanding (liquidation preference of $700,782 and $693,580) as of March 31, 2022 and December 31, 2021, respectively 700,782 693,580
STOCKHOLDERS’ EQUITY (DEFICIT)    
Common stock, $0.0001 par value, 300,000,000 shares authorized, 1,686,587 and 1,652,102 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 169 165
Unearned deferred compensation (687,701) (900,742)
Additional paid-in capital 30,159,461 29,765,585
Accumulated deficit (31,111,145) (29,281,674)
TOTAL STOCKHOLDERS’ DEFICIT (1,639,214) (416,664)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 965,074 1,669,880
Series B Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY (DEFICIT)    
Preferred stock, value 2 2
Series E Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY (DEFICIT)    
Preferred stock, value